CB1 expression was initially higher in the selective hippocampal areas and gradually decreased as AD progressed, clearly indicating the involvement of CB1 receptors during the earlier stages of AD (Manuel et al., 2014). This evidence concerns the gene CNR1 and Alzheimer disease.